Allogenic mesenchymal stem cells therapy(Aarhus University Hospital)

N/A

Report date: 2023/07/07 20:01:23

Base Information

Drug NameAllogenic mesenchymal stem cells therapy(Aarhus University Hospital)

Drug Alias NameAllogenic adipose derived mesenchymal stem cells (AD-MSC)(Aarhus University Hospital)

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsOsteoarthritis, Knee

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAarhus University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesAarhus University Hospital

Inactive CompaniesN/A

Active IndicationsOsteoarthritis, Knee

Inactive IndicationsN/A

Other Information

ATC CodeN/A